We are live on ! Find out more

1,034 hedge funds and large institutions have $51.1B invested in DexCom in 2024 Q1 according to their latest regulatory filings, with 156 funds opening new positions, 404 increasing their positions, 348 reducing their positions, and 86 closing their positions.

New
Increased
Maintained
Reduced
Closed

81% more first-time investments, than exits

New positions opened: 156 | Existing positions closed: 86

16% more repeat investments, than reductions

Existing positions increased: 404 | Existing positions reduced: 348

8% more capital invested

Capital invested by funds: $47.1B → $51.1B (+$3.99B)

6% more funds holding

Funds holding: 9751,034 (+59)

0% more funds holding in top 10

Funds holding in top 10: 2525 (0)

2.73% less ownership

Funds ownership: 98.38%95.65% (-2.7%)

11% less call options, than puts

Call options by funds: $686M | Put options by funds: $770M

Holders
1,034
Holders Change
+59
Holders Change %
+6.05%
% of All Funds
14.86%
Holding in Top 10
25
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.36%
New
156
Increased
404
Reduced
348
Closed
86
Calls
$686M
Puts
$770M
Net Calls
-$84.2M
Net Calls Change
+$144M

DXCM Hedge Fund Activity: Q1 2024 in Review

1,034 of the 6,958 institutional investors tracked by Wall St. Rank reported a position in DexCom (DXCM) for Q1 2024, worth a combined $51.1B — up 8.5% from $47.1B a quarter earlier.

Buyers outnumbered sellers: 156 funds opened new DXCM positions and 86 closed out — a net gain of 70 holders — while 404 added to existing stakes and 348 trimmed.

The largest buyer was DZ Bank, adding an estimated $639M. The largest seller was Sands Capital Management, cutting an estimated $523M.

  • 1,034 institutional investors held DexCom (DXCM) as of Q1 2024, up from 975 in Q4 2023.
  • Funds reported $51.1B of DexCom stock for Q1 2024, up 8.5% quarter-over-quarter.
  • 156 funds opened new DexCom positions in Q1 2024 and 86 closed out, a net change of +70 holders.
  • The largest DexCom buyer in Q1 2024 was DZ Bank, an estimated $639M added.
  • The largest DexCom seller in Q1 2024 was Sands Capital Management, an estimated $523M sold.

Based on aggregated 13F filings for Q1 2024.